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Huntington's DiseaseThe ability of isolated brain mitochondria to accumulate, store and release calcium has been extensively
characterized. Extrapolation to the intact neuron led to predictions that the in situ mitochondria would
reversibly accumulate Ca2+ when the concentration of the cation in the vicinity of the mitochondria rose
above the ‘set-point’ at which uptake and efﬂux were in balance, storing Ca2+ as a complex with phosphate,
and slowly releasing the cation when plasma membrane ion pumps lowered the cytoplasmic free Ca2+.
Excessive accumulation of the cation was predicted to lead to activation of the permeability transition, with
catastrophic consequences for the neuron. Each of these predictions has been conﬁrmed with intact neurons,
and there is convincing evidence for the permeability transition in cellular Ca2+ overload associated with
glutamate excitotoxicity and stroke, while the neurodegenerative disease in which possible defects in
mitochondrial Ca2+ handling have been most intensively investigated is Huntington's Disease. In this brief
review evidence that mitochondrial Ca2+ transport is relevant to neuronal survival in these conditions will
be discussed.© 2009 Elsevier B.V. All rights reserved.2+Isolated, respiring mitochondria accumulate Ca when the
concentration of the cation in their immediate environment rises
above the ‘set-point’ at which the rates of uptake via the Ca2+
uniporter and efﬂux via themitochondrial Na+/Ca2+ exchanger are in
balance [1] (Fig. 1a). With isolated brain mitochondria under plausibly
physiological conditions in the presence of external adenine nucleo-
tides and phosphate the set-point is close to 0.5 μM [2], (Fig. 1a), and
this closely corresponds to values estimated for net Ca2+ accumula-
tion by mitochondria in situ within cultured neurons [3–6]. When
more than 10 nmol of Ca2+/mg protein has been taken up, the parallel
accumulation of phosphate leads to the formation of a calcium–
phosphate complex in the matrix which effectively buffers the free
matrix Ca2+ ([Ca2+]m) at about 0.2 to 2 μM [7,8], (Fig. 1c), similar
values being reported for in situ neuronal mitochondria [9]. The
calcium–phosphate complex is maintained by the high matrix pH [8]
and its composition has been investigated by Kristian et al. [10] who
performed X-ray spectral analysis of calcium–phosphate precipitates
in rapidly frozen Ca2+-loaded brain mitochondria and reported a
variable calcium to phosphate ratio depending on loading conditions,
suggesting that the composition of the complex is somewhat ﬂexible.
This matrix Ca2+ complexation in turn clamps the activity of the Na+/
Ca2+ exchanger at a value that is independent of any further increase
in total matrix Ca2+ [11], (Fig. 1b), and under these conditions the set-
point is independent of the total matrix Ca2+. The result is that the
isolated mitochondria can act as perfect ‘buffers’ of free Ca2+ in their
vicinity, responding to multiple additions of Ca2+ to the medium byll rights reserved.lowering the extra-mitochondrial free Ca2+ concentration ([Ca2+]e)
back to the set-point after each addition (Fig. 1d). This can continue
until in excess of 500 nmol Ca2+/mg protein has been accumulated
and the onset of bioenergetic collapse associated with the perme-
ability transition [8].
The inference from these in vitro studies is that mitochondria
within intact neurons will act as temporary reversible stores of Ca2+,
accumulating the cation when the cytoplasmic free Ca2+ ([Ca2+]c) is
above the set-point, for example following a train of action potentials,
and releasing the cation back to the cytoplasm when the plasma
membrane Ca2+-ATPases succeed in pumping down [Ca2+]c to below
the set-point in the subsequent resting phase. As will be discussed
below, there is convincing evidence that this occurs in intact neurons,
lowering peak values of [Ca2+]c but extending the duration of elevated
cytoplasmic Ca2+, and modulating cell signaling and transmitter
release.
For this cytoplasmic buffering to occur with no deleterious
consequences for the mitochondria and hence the cell, it is clearly
essential that the period during which [Ca2+]c is elevated above
the set-point is brief to avoid mitochondrial Ca2+ overload. If
however a tonic activation of Ca2+ entry pathways across the
plasma membrane is sufﬁcient to retain [Ca2+]c above the set-
point, then an inexorable accumulation of Ca2+ within the matrix
will occur until maximal capacity is exceeded and the permeability
transition ensues, initiating rapid necrotic cell death. Conversely, in
a quiescent neuron where [Ca2+]c is close to 0. 1 μM the
mitochondrial matrix will be largely depleted of Ca2+, the
calcium–phosphate complex will not form and [Ca2+]m will vary
as a function of [Ca2+]c. Isolated mitochondria smoothly transition
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below 10 nmol/mg [8]. This ‘regulatory’ rather than ‘storage’ range
can control the activity of the TCA cycle in many cells (reviewed in
[12]).
Under conditions of respectively, low, intermediate and excess
matrix Ca2+ accumulation, mitochondria in neurons may therefore beinvolved in intra-mitochondrial metabolic regulation, in controlling
the extent and duration of cytoplasmic Ca2+ elevations and in the
extreme case in the very life or death of the neuron. Studies on the
roles of mitochondrial Ca2+ transport in the brainmay thus be divided
into the ‘physiological’ where the uptake of Ca2+ into the matrix is
reversible and serves a regulatory role and the ‘pathological’ that
generally involves activation of the mitochondrial permeability
transition. These will now be considered separately.
1. ‘Physiological’ transport of Ca2+ by brain mitochondria
Mitochondrial Ca2+ uptake in neurons may play multiple roles,
including facilitating the uptake of Ca2+ through voltage and receptor
activated Ca2+ channels and decreasing feedback inhibition by a sub-
membrane ‘calcium cloud’ [13]. Mitochondria will also compete with
the plasma membrane and endoplasmic reticulum Ca2+-ATPases for
cytoplasmic Ca2+. Mitochondria could also prolong periods of
elevated [Ca2+]c in stimulated neurons by reversibly sequestering
and releasing the cation. David and Barrett [14,15] have investigated
how inhibition of mitochondrial Ca2+ transport affects quantal release
of transmitter during repetitive stimulation of mouse motor nerve
terminals. Comparing responses in the presence of oligomycin with
those after oligomycin plus antimycin A (to control for bioenergetic
effects) the authors concluded that mitochondrial Ca2+ uptake
prevented desynchronization of quantal release and minimized
depletion of releasable vesicles during tetanic stimulation. In contrast,
inhibition of e.r. Ca2+ uptake with cyclopiazonic acid had minimal
effects on [Ca2+]c or quantal release.
In investigating the physiology and pathology of neuronal
mitochondrial Ca2+ transport, however, it is important to take a
holistic view of the mitochondrion and its in situ bioenergetics, rather
than focusing purely on the transport of the cation. Thus an elevation
in [Ca2+]c sufﬁcient to allow net mitochondrial Ca2+ accumulation
imposes a dual energetic demand on the mitochondrial proton circuit.
Firstly the elevation in [Ca2+]c will activate plasma membrane and
endoplasmic reticulum Ca2+-ATPases with a resultant increase in ATP
demand. Secondly, the direct uptake of the cation into the matrix
utilizes the proton circuit and directly competes with mitochondrial
ATP synthesis. Indeed it was shown many years ago that a high rate of
Ca2+ uptake could even lower the protonmotive force sufﬁciently to
cause a transient reversal of the ATP synthase [16].
1.1. Isolated mitochondria
Brain mitochondrial preparations are inherently heterogeneous
[7], as well as differing in Ca2+-sensitivity between strains [17] and
brain regions [18,19]. ‘Non-synaptic’ mitochondria obtained by
density gradient centrifugation include mitochondria from neuronal
cell bodies and glia. Treatment of the crude mitochondrial pellet
with low concentrations of digitonin liberates pre-synaptic mito-
chondria from the associated synaptosomes [20]. Alternatively,
mitochondria can be prepared from cultured neurons and glia by
nitrogen cavitation [21].
When determining Ca2+ uptake by mitochondria, a clear distinc-
tionmust bemade between the free and total cation. Determination ofFig. 1. Ca2+ transport by isolatedmitochondrial. (a) Kinetics of Ca2+ uptake via the Ca2+
uniporter in rat liver mitochondria as a function of external free Ca2+ concentration. (b)
Kinetics of Ca2+ release via the Ca2+/2H+ exchanger in rat liver mitochondria as a
function of matrix Ca2+ load; Ac, phosphate depleted mitochondria in the presence of
5mMacetate, Pi, mitochondria in the presence of 3. 3mMphosphate. The efﬂux rate in Pi
is independent of total matrix Ca2+ because free matrix Ca2+ is buffered by the Ca2+-
phosphate complex. (c) Rat liver mitochondrial matrix free Ca2+ concentration as a
function of matrix Ca2+ load. Note the transition from varying to buffered free Ca2+ at
10 nmol Ca2+/mg when the Ca2+ phosphate complex starts to form. (d) Rat brain
mitochondria buffer the external free Ca2+ concentration close to 0.25 μM inMg2+-free
media. For experimental details see [2,8,11].
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deﬁned amounts of Ca2+ can be added to the incubation while
monitoring [Ca2+]e to ensure uptake into the matrix [22]. Alterna-
tively Ca2+ can be released into the incubation by addition of a
protonophore, although experiments with isolated mitochondria
suggest that not all the Ca2+ accumulated in the presence of
phosphate is readily released by protonophore [10].
1.2. Mitochondrial Ca2+ transport in intact neurons
Early functional imaging studies of neurons with cytoplasmic
free Ca2+ ([Ca2+]c) indicators [23] demonstrated that the neuronal
cytoplasm can experience large elevations in [Ca2+]c under a variety
of stimulation conditions including elevated KCl [24], high
frequency ﬁeld stimulation [4] and NMDA receptor activation [25].
It was therefore predicted that the in situ neuronal mitochondria
would reversibly accumulate Ca2+ in response to elevated [Ca2+]c
[26]. Werth and Thayer [4] obtained evidence that mitochondria in
cultured rat dorsal root ganglion neurons reversibly accumulated
calcium in response to high frequency ﬁeld stimulation, and this
was subsequently extended by different groups to KCl and
glutamate induced calcium loading [13,27,28]. It is relevant to
note that the ‘set-points’ determined for isolated mitochondria [2]
correspond closely to those reported for intact neurons [4], and that
the values for [Ca2+]m reported for Ca2+-loaded in situ neuronal
mitochondria also closely correspond to values obtained with
isolated mitochondria [8]. This suggests that neuronal mitochondria
do not utilize adjacent endoplasmic reticulum to facilitate their Ca2+
accumulation, and may thus differ from mitochondria in cell lines with
extensive e.r. [29].
As in the case of isolated mitochondria, it is important to maintain
the distinction between total and free matrix Ca2+ in intact neurons.
David et al. [9], see also [30,31], monitored [Ca2+]m in lizard motor
terminals during trains of action potentials, using the low-afﬁnity
matrix-located indicator rhod-5N (Kd 320 μM). [Ca2+]m increased to a
plateau close to 1 μM. Importantly, increasing the frequency of
stimulation increased the rate at which [Ca2+]m rose to this plateau,
but did not affect the plateau itself, suggesting that the matrix has a
large capacity to buffer Ca2+ at this value. This closely corresponds to
the data obtained with isolated mitochondria [8], where the calcium–
phosphate complex maintained [Ca2+]m at about 2 μM over a 50-fold
range of total Ca2+ [8]. In contrast values for [Ca2+]m reported using
targeted aequorins tend to be considerably higher, e.g. [32]. The
reasons for these discrepancies remain to be elucidated.
The speciﬁc, focused manipulation of mitochondrial Ca2+ in intact
neurons is not trivial. Early studies where protonophores were
employed to depolarize the mitochondria [6,33] of course dramati-
cally affected the cell's bioenergetics. In cells with a high glycolytic
capacity, the role of mitochondrial Ca2+ transport can be investigated
by comparing cell function in the presence of oligomycin with that in
the presence of oligomycin plus an electron transport chain inhibitor
[13]. Since ATP generation is already glycolytic following oligomycin,
the further addition of an electron transport inhibitor will allow Δψm
(and hence mitochondrial Ca2+ transport) to decay with no further
effect on the cell's bioenergetics. Even the widely employed Ca2+
ionophore ionomycin must be used with great care, since it induces a
dissipative Ca2+ cycling across the inner mitochondrial membrane
[34]. Since [Ca2+]c (and hence Ca2+ uniport activity) is elevated by the
ionophore's action at the plasma membrane, this induces a potent
mitochondrial uncoupling manifested by increased respiration [35].
Indeed low micromolar concentrations of the ionophore can collapse
the mitochondrial membrane potential (Δψm) in cultured neurons
leading to rapid necrotic cell death [34]. It would be instructive to
determine the proportion of the 20,000 references in the literature
utilizing such Ca2+ ionophores where this underlying bioenergetic
effect is an unrecognized complication. It is generally accepted thatthe hexavalent cation ruthenium red is impermeant across the plasma
membrane of most cells and that it acts by inhibiting Ca2+ uptake into
the cell (reviewed in [36]). Ru360 has been proposed to be a more
selective, cell permeant uniport inhibitor [37], but again there is
considerable uncertainty as to its ability to enter cells and act
speciﬁcally at the mitochondrial Ca2+ uniporter [15,36].
2. ‘Pathological’ transport of Ca2+ by brain mitochondria
2.1. Isolated mitochondria
As will become apparent in this review, much of the investigation
into the role of mitochondrial Ca2+ transport in CNS diseases has
focused around the induction of the permeability transition. There has
been some controversy over the nature or even existence of the
permeability transition in isolated brain mitochondrial preparations.
In part this is because the light-scattering changes of isolated brain
mitochondria during Ca2+ loading differ from e.g. liver mitochondria.
The initial stages of Ca2+ accumulation by non-synaptic brain
mitochondria produce an increase in light-scattering, probably due
to the increased refractive index of the Ca2+ loaded matrix [8]. An
early study [38] showed that cyclosporine A (CsA) failed to protect
cultured hippocampal neurons against mitochondrial swelling and
depolarization associated with Ca2+-ionophore-induced Ca2+ load-
ing, although as discussed above this could have been a consequence
of the unrecognized bioenergetic consequences of the ionophore
addition. Subsequently, the ability of CsA to decrease the Ca2+-
sensitivity of isolated brain mitochondria has been shown by several
groups [18,39,40]. In the presence of adenine nucleotides, it was found
that the capacity of non-synaptic brain mitochondria to accumulate
Ca2+ during the slow continuous infusion of the cation could be
further increased (from 600 to 1500 nmol/mg protein) in the
presence of CsA [8].
The nature and regulation of the mitochondrial permeability
transition have been extensively reviewed recently [41] and discus-
sion here will be limited to the brain. The calcium loading capacity of
isolated brain mitochondria has traditionally been determined by
sequential bolus additions of the cationwhile monitoring the ability of
the mitochondrial incubation to restore a low free Ca2+ concentration
in the incubation. However, since each bolus addition creates a
transient energy demand on the mitochondria while affecting
mitochondrial membrane potential and matrix pH these may distort
an accurate estimation of loading capacity which can be avoided by
slowly perfusing calcium into the medium while monitoring the
external free calcium concentration [8]. Under these conditions
loading capacity can be separated from the bioenergetic demands
that accompany bolus additions.
There is disagreement in the literature as to the ability of cyclo-
sporine to delay the permeability transition during massive calcium
loading. Species differences are frequently ignored, but it is
signiﬁcant that non-synaptic brain mitochondria from C57Bl/6J
mice are able to accumulate approximately twice as much Ca2+ as
the corresponding mitochondria from Sprague–Dawley rats before
induction of the permeability transition [17]. Synaptic mitochondria
prepared from synaptosomes are more sensitive to Ca2+, have a
higher level of cyclophilin D and are more vulnerable to the
permeability transition unless cyclosporine A is present [42–44].
Knock-down of cyclophilin D in PC12 cells decreases their
sensitivity to the permeability transition [42] and mitochondria
from CypD-knockout mice are resistant to the permeability
transition [45]. Some of the variation in reported CsA sensitivity
was explained by the observation of Bambrick et al. [46] that only
astrocytic (but not neuronal) mitochondria displayed a CsA-
sensitive Ca2+ accumulation capacity. In addition permeabilized
astrocytes could accumulate more Ca2+ than permeabilized granule
neurons on a per-cell or mitochondrial protein basis. Thus a failure
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evidence against a permeability transition. A number of cyclospor-
ine A analogues have been developed that are more potent against
the permeability transition while being less active as immuno-
suppressants and calcineurin inhibitors [47–50] and can therefore
provide less ambiguous information on the permeability transition
in intact cells than CsA.
Even though the permeability transition is likely to be a
stochastic process at the level of the individual mitochondrion, the
release of Ca2+ from an individual mitochondrion will increase the
Ca2+ concentration in its neighborhood. In a very dilute incubation
(e.g. 0.05 mg protein/ml in a perfusion study [8]) the likelihood is
that Ca2+ released by the neuronal sub-fraction will be accumulated
by the astrocytic mitochondria and that the overall incubation will
show the CsA sensitivity characteristic of the latter. However, in a
relatively concentrated isolated mitochondrial incubation, and even
more so in the intact cell, the probability of a chain reaction of Ca2+
overload following an initial permeability transition in a sub-
population will increase, in which case the mixed population
might show the CsA-independent characteristics of the neuronal
sub-population.
2.2. Monitoring the permeability transition in intact neurons and in vivo
The permeability transition in isolated mitochondrial preparations
can bemonitored by decreased light-scattering, release of cytochrome
c, Ca2+ and low molecular weight matrix components and collapse of
Δψ. In the intact cultured neuron mitochondrial swelling can readily
be detected by confocal imaging as a thread-like to globular shape
transition reﬂecting matrix Ca2+ loading [51,52] but this cannot
automatically be equated with the permeability transition since it can
in many cases be reversed with no apparent loss of function [51,53].
Mitochondria that have undergone the permeability transition are
depolarized and do not accumulate membrane potential indicators,
and are thus not visible in ﬂuorescent microscopy. Elmore et al. [54]
have employed the loss of ﬂuorescence resonance energy transfer
(FRET) between the membrane potential-independent MitoTracker
Green and TMRM+ and the resulting increase in direct MitoTracker
ﬂuorescence emission to provide a positive signal reﬂecting mem-
brane potential collapse. An alternative method has involved the
cytoplasmic loading of calcein, which leaves dark ‘holes’ correspond-
ing to the mitochondria. Activation of the permeability transition
leads to entry of calcein into the matrix and the disappearance of the
holes [55].
3. Mitochondrial calcium transport in CNS disease
Neuronal dysfunction can be modeled by reproducing the actual
insult in the intact animal (e.g. vessel occlusion in stroke studies)
followed by isolation of mitochondria or synaptosomes. Alterna-
tively, cell cultures can be exposed to stresses related to those
experienced in vivo (e.g. glutamate exposure of neuronal cultures to
simulate the glutamate excitotoxicity associated with ischemia). The
limitation with this approach is that the cell cultures are neonatal
and may thus lack the critical age-related changes that play such a
major role in the incidence of most neurodegenerative diseases. In
addition the normal physiological interconnections and glial inter-
actions are usually missing, while in the speciﬁc case of calcium
transport, the extra-cellular volume in cell culture is vast compared
with in vivo and the essentially inﬁnite extra-cellular Ca2+
compartment may exaggerate the magnitude of Ca2+ accumulation
occurring in vivo.
The role of mitochondrial Ca2+ in this context can be approached
at several levels, starting with the isolated mitochondria, and ranging
through cell lines (including cybrids), primary neuronal cultures,
isolated nerve terminals (synaptosomes), acute and organotypictissue slices to in vivo rodent models. Except in the few cases where
human material is available the neuronal dysfunction has to be
created, for example by mouse genetic manipulation. If there is
sufﬁcient evidence to implicate an alteration of mitochondrial
function, for example impaired Complex I function in Parkinson's
disease (PD), then the consequence of this can be investigated by in
vitro or in vivo addition of Complex I inhibitors, although of course the
relevance of the model is entirely dependent upon the strength of the
in vivo evidence, and this approach gives little indication of the
upstream or parallel events that might have caused the dysfunction in
the disease itself. However, a similar pathology between the human
disease and a chemical intervention is encouraging-for example the
demonstration that systemic rotenone in rodents can cause a similar
striatal pathology to the disease [56].
While the focus of this review is on Ca2+ and its involvement in
CNS dysfunction, it is essential to bear in mind that mitochondrial
Ca2+ transport, oxidative stress and bioenergetics form a closely
inter-related network. Deﬁcient ATP generation in a cell can lead to
a failure of plasma membrane Ca2+ pump activity and Ca2+ overload;
oxidative stress can restrict ATP generating capacity. Ca2+ uptake into
the cell and its further transport into the mitochondrion can put a
heavy load on the mitochondrial proton circuit, in some cases leading
to neuronal cell death induced by an energy crisis [57]. While it is
frequently stated that Ca2+ accumulation by in situ mitochondria
results directly in oxidative stress, there is no known mechanism to
cause this, and indeed a decrease rather than an increase in H2O2 is
seen in respiring isolated rat brain mitochondria as they accumulate
Ca2+, consistent with a lowered Δψ [58].
As previously mentioned, much of the literature on mitochondrial
Ca2+ and neurological disease has focused on the permeability
transition. These studies have recently been extensively reviewed in
relation to excitotoxicity [59], ischemia [60], traumatic brain injury
[61], and Parkinson's and Alzheimer's diseases [62]. A central question
must be posed about any in vitro experiment in this context, and that
is whether the proposed involvement of the permeability transition
holds for the in vivo condition, rather than being an in vitro
phenomenon, and if it does, whether it is directly mediated by some
dysfunction unique to the disorder, of whether it is a more general
manifestation of excitotoxicity. Finally, even if excitotoxicity is
implicated as the underlying mechanism in the neuronal cell death,
is it in turn caused by altered Ca2+ handling by the mitochondrion, by
oxidative stress (e.g. [63–65]), by impaired mitochondrial metabolism
or energetics (e.g. [57,66,67]) or mitochondrial trafﬁcking in the
neuron (e.g. [68]), by altered ion transport at the plasmamembrane or
by some to other subtle prime cause? These questions of course
determine whether it is worthwhile to look for changes in Ca2+
handling of isolated brain mitochondria from disease models or
whether cell culture or ex vivo preparations such as synaptosomes are
more appropriate.
In this author's opinion, there is convincing evidence for the
involvement of the permeability transition in excitotoxicity from the
level of the cultured neuron to in vivo in association with stroke,
ischemia, traumatic brain injury and other conditions associated with
receptor-mediated cell Ca2+ overload. With the possible exception of
Huntington's Disease (HD) evidence for a defect at the level of isolated
mitochondrial Ca2+ transport is sparse. The remainder of this short
review will therefore focus on in vitro and in vivo excitotoxicity and
models of HD.
3.1. Glutamate excitotoxicity and stroke
The strongest evidence for a patho-physiological role for the
permeability transition occurs in the context of neuronal cell death in
the aftermath of stroke as a result of glutamate excitotoxicity. Chronic
NMDA receptor activation by glutamate released from a focal infarct
underlies the progressive expansion of the volume of necrotic tissue in
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that are important for the primary roles of the receptor in learning and
memory, namely Ca2+ as well as Na+ transport and only partial
desensitization in the continued presence of the ligand, are potentially
lethal for the neurons in the penumbra surrounding the infarct. The
mechanism of the resulting cell death as a consequence of ‘glutamate
excitotoxicity’ has been extensively studied at the level of the cultured
neuron and some of the earliest studies from the group of Choi [70–
73] established the essential role of Ca2+ in cell death resulting from
chronic NMDA receptor activation. Cortical neurons exposed to
glutamate in the absence of calcium underwent extensive osmotic
swelling, and in the presence of the cation this was followed by a
delayed neuronal disintegration [71]. Choi proposed that calcium
entry through the NMDA receptor played a dominant role in the
subsequent cell death. Randall and Thayer [25] monitored real-time
change in cytoplasmic free calcium in hippocampal neurons exposed
to glutamate and found that cell necrosis was preceded by a delayed
massive rise in cytoplasmic free calcium concentration. This was
further investigated by Tymianski et al. [74] who extensively
examined the conditions for this stochastic ‘delayed calcium dereg-
ulation’ and concluded that the location of calcium entry was equally
or more important than the total calcium uptake, although subse-
quent studies with low-afﬁnity calcium probes [75] have revised this
view.
The studies with isolated mitochondria discussed above led to
predictions that the intra-neuronal mitochondria would be major
sinks of calcium entering the neurons under conditions of extensive
calcium loading and elevated cytoplasmic free calcium. In particular,
if the non-desensitizing conductance of the NMDAR in the presence
of exogenous glutamate is sufﬁcient to maintain [Ca2+]c above the
Ca2+ set-point for the in situ mitochondria, then the organelles will
inexorably load with Ca2+ until their capacity is exceeded [13]. It is
notable that an inverse relationship is seen at a single cell level in a
population of cultured neurons exposed to glutamate between the
extent of the immediate slight Δψm depolarization reﬂecting the rate
of Ca2+ accumulation into the mitochondria, and the survival time
before the neurons undergoes delayed Ca2+ deregulation [76]. The
extent of delayed calcium deregulation was found to be proportional
to the time for which mitochondria remained polarized, suggesting
that a critical factor was the amount of calcium accumulated by the
mitochondria [77]. Furthermore, cells with active glycolysis could be
protected against delayed calcium deregulation by inhibiting
mitochondrial calcium accumulation with the combination of
rotenone and oligomycin [13]. Interestingly, bulk cytoplasmic free
calcium elevations in response to glutamate were depressed by this
combination of inhibitors in these cells [77]. Since no decrease in
calcium entry was detected, it was concluded that inhibition of
calcium uptake by mitochondria in close apposition to the plasma
membrane calcium ATPase could remove a competition between the
mitochondria and the ion pump for calcium and enhance net
calcium extrusion from the cell.
Cell death in response to mitochondrial calcium loading immedi-
ately suggests the involvement of the permeability transition.
However, no consistent protection was been reported for cultured
cerebellar granule neurons exposed to glutamate in the presence of
inhibitors of the permeability transition pore such as cyclosporine A
[77], while mitochondria isolated from these cells showed no
protection by cyclosporine A [78]. This is in contrast to the extensive
protection afforded by the inhibitor during calcium loading of isolated
brain mitochondria [8]. However, the report of cyclosporine A-
sensitive Ca2+ accumulation by mitochondria prepared from the
synaptosomal fraction [79] indicates that there remain questions
concerning the cellular and sub-cellular localization of permeability
transition-prone mitochondria.
Mitochondria in glutamate exposed cultured neurons undergo an
extensive swelling that is associated with a cessation of trafﬁckingwithin the neurite and dendritic beading [52,80–81]. Synchronous
with the elevations in cytoplasmic free calciummitochondria undergo
a massive depolarization [76]. The matrix pH changes associated with
glutamate exposure are particularly revealing; from a starting pH
close to eight a transient alkalinization is seen, followed by an
acidiﬁcation of the matrix to pH of about 7.1. At the same time a
cytoplasmic acidiﬁcation occurs and the Delta pH across the
membrane is largely retained [82]. Delayed calcium deregulation is
associated with a further matrix acidiﬁcation and the abolition of the
proton gradient. It is notable that the matrix acidiﬁcationwill lead to a
destabilization of the extensive matrix calcium–phosphate precipi-
tate, and would be predicted to greatly increase the matrix free Ca2+
[8]. Since themembrane potential and pH gradient collapse during the
cytoplasmic calcium deregulation, and respiration is inhibited [83]
this is consistent with a permeability transition.
While much of the focus in excitotoxicity is on Ca2+ transport, it
must be born in mind that the NMDAR allows the entry of both Ca2+
and Na+. Indeed, even though a typical NMDARmay have a Ca2+/Na+
selectivity of about 10, the concentration of Na+ in the external
medium is 100-fold higher than Ca2+ with the result that Na+ entry
dominates. Recent studies on the bioenergetic demand of the
resultant activation of the Na+/K+-ATPase to extrude the cation
[84] have shown that under some circumstances the entire ATP
generating capacity of the in situ mitochondria can be diverted to
provide ATP for the Na+/K+-ATPase and accordingly that a variety of
stresses that are in themselves non-lethal, such as partial Complex I
inhibition [84], ‘mild uncoupling’ [85] and oxidative stress following
glutathione depletion [83] can result in a bioenergetic deﬁciency that
leads to rapid necrotic cell death. It is therefore important to bear in
mind that Ca2+-sensitivity in ischemic models can be greatly
ampliﬁed by factors that limit ATP generation, as ﬁrst proposed by
Henneberry [86], see also [66].
Cyclosporine A has been shown to be neuroprotective in vivo in
both focal and global ischemia [87,88]. The ultimate test for the
involvement of the permeability transition in glutamate excitotoxicity
accompanying cerebral ischemia is to investigate the in vivo
consequences of Cyp-D knockout. Liver, heart and brain mitochondria
from Cyp-D deﬁcient mice are resistant to Ca2+-induced swelling and
show a capacity to accumulate Ca2+ equal to those from control mice
in the presence of cyclosporine A [45,89,90]. Importantly, the infarct
volume 24 h after middle cerebral artery occlusionwas reduced to less
than 50% of control values [89].
3.2. Mitochondrial Ca2+ transport in models of Huntington's disease
Huntington's disease is the most studied of the group of
autosomal-dominant trinucleotide repeat expansion diseases that
include at least 10 poly-Q disorders (reviewed in [67,91,92]). The
affected protein is huntingtin (htt) and the threshold for pathology
occurs at N36 Q repeats, corresponding to the appearance of
aggregated htt. The severity and age of onset of symptoms are related
to the repeat length which can be up to 120 Q. Htt is an essential
protein that is widely expressed in cells; thus the homozygous
knockout mouse dies in embryo and heterozygous deletion of the htt
gene results in neurodegeneration [92]. Despite this, its normal
function is still debated. There is evidence that it functions as a nucleo-
cytoplasmic shuttling protein involved in the regulation of transcrip-
tion [91], and that it affects trafﬁcking in neurons [93], while
mitochondrial interactions have been shown [94]. HD is an aging-
related disease and it has been proposed that a change in function of
the expanded htt accelerates normal aging-related changes in the
brain [91]. A variety of transgenic mouse models of HD have been
developed. Those expressing truncated human htt (e.g. R6/2 and R6/
1) have a severe and widespread pathology and are severely diabetic,
while those expressing full-length expanded human htt on a yeast
artiﬁcial chromosome, such as the YAC128 mouse, show more
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endogenous mouse htt generally display a mild phenotype [95].
Post-mortem analysis of mitochondrial respiratory chain complex
activities from HD patients revealed a greater than 50% reduction in
Complex II and Complex III activity, relative to protein or citrate
synthase activity in the caudate, with a lesser decrease in Complex IV
and no change in Complex I [96]. The putamen showed a more than
60% reduction in complex activities (again with the exception of
Complex I) [97]. Cybrid technology, where platelets from HD patients
were fused with SH-SY5Y neuroblastoma cells, failed to reveal any
bioenergetic differences from control samples suggesting that nuclear
DNA can correct any deﬁciencies in the platelets' mitochondria [98].
As in the case of Parkinson's disease there is therefore persuasive
evidence for respiratory chain dysfunction in the mitochondria of the
surviving cells. It is therefore important in the present context to
establish whether any apparent change in mitochondrial Ca2+
handling reﬂects a primary action on mitochondrial transport or
storage, or is a downstream consequence of the inhibited bioenergetic
function.
The close association between restricted bioenergetic function and
enhanced susceptibility to excitotoxicity has been discussed above.
Indeed there is extensive evidence (reviewed in [99]) for the
involvement of NMDAR function and excitotoxicity in cell death
associated with HD. Signiﬁcantly, a YAC transgenic mouse expressing
72 CAG repeats in htt showed enhanced glutamate excitotoxicity in
vivo and in cultures of striatal medium spiny neurons [100], while the
NMDAR antagonist MK801 reduced malonate-induced striatal cell
death in vivo although it was without effect on lesion size in
transgenic R6/1 mice [101]. The excitotoxic cascade discussed above
may thus contribute to the neuronal susceptibility in HD, although the
high susceptibility of the background strain (FVB/N) to excitotoxicity
[102] means that the ﬁndings cannot automatically be extrapolated to
the human disease. Fernandez et al. [99] monitored [Ca2+]c and Δψm
in parallel in single medium spiny neurons prepared from wild-type
and YAC128 mice and observed that maximal NMDAR activation
induced DCD (collapse ofΔψm and failure to restore basal [Ca2+]c after
removal of NMDA)in the YAC128 neurons but not wild-type. No
signiﬁcant difference was observed in NMDAR currents and it was
concluded that the mitochondria in the YAC128 cells were more
sensitive to the permeability transition. A similar conclusion was
reached in a study with immortalized striatal cells derived from Q111
mice [103], however again caution must be exerted in implying an
excitotoxic mode of neuronal death in the disease.
While experimental Complex II deﬁciency with malonate or 3-
nitropropionic acid (3NPA) can reproduce some of the pathology of
the disease [104–106], using these inhibitors to ‘model’ the disease in
vitrowill not take account of any parallel or upstream consequences of
the in vivo pathology and should be interpreted with caution.
The synergism between impaired mitochondrial ATP generation
and susceptibility to glutamate excitotoxicity discussed above in the
context of stroke is also apparent in striatal cultures exposed to 3NPA
[107]. However somewhat surprisingly in view of the impaired
mitochondrial bioenergetics implicated in the in vivo disease, the
R6/1 and R6/2 mice show an increased resistance to glutamate
excitotoxicity induced by quinolinic acid in vivo [108,109] which could
not be ascribed to decreased NMDA receptor expression but which
correlated with the appearance of nuclear inclusions. It was proposed
that mutant htt causes a sub-lethal metabolic stress that causes cell
defense mechanisms to be up-regulated against subsequent excito-
toxic insult [101]. Thus medium spiny neurons from R6/2 mice
showed an increased basal [Ca2+]c while at the same time being more
resistant to quinolinate-induced delayed Ca2+ deregulation [109].
Many studies have been performed with isolated brain mitochon-
dria, with the constraints due to heterogeneity discussed above. In
particular, since there is evidence that a normal physiological role of
htt is in the control of anterograde/retrograde transport in neurons[93] isolated mitochondrial preparations will not be able to detect
bioenergetic defects that are a consequence of an altered distribution
of mitochondria throughout the neuron. A study by Panov et al. [110]
investigated Ca2+ transport in mitochondria prepared from trans-
formed lymphocytes of control and HD patients and observed that the
latter were depolarized by 12mV relative to the controls and showed a
signiﬁcant reduction in their Ca2+ accumulation capacity in the
absence of exogenous adenine nucleotides. Similar reductions in Δψ
and Ca2+ accumulation capacity in the presence of ADP and
cyclosporine A were seen in brain mitochondria from transgenic
mice expressing a yeast artiﬁcial chromosomewith 72, but not 18, CAG
repeats [110]. No difference in basal [Ca2+]e was shown, but the YAC72
mitochondria took up Ca2+ more slowly than those from YAC18 mice.
In view of the reported respiratory chain defects it is possible that the
slowed Ca2+ uptake, and the partial initial depolarization reﬂects an
inhibited respiratory chain. Respiratory parameters were not quanti-
ﬁed in this study [110] but a subsequent study revealed no differences
in respiratory rates between lymphoblast mitochondria derived from
control and HD subjects [111].
Interestingly some effect was shown from the direct addition of
5 μMhtt fusion proteins with long but not short Q-repeats [110]. It was
however subsequently reported that the fusion proteins exerted a
direct inhibitory effect on the respiration of liver and lymphoblast
mitochondria [94].
A decreased Ca2+-accumulation capacity was reported for mito-
chondria prepared from clonal striatal cell lines containing expanded
htt [112], but a detailed study by Brustovetsky et al. [18] presented
different conclusions-no increase in Ca2+-sensitivity was observed
between striatal mitochondria from control and HD mice (knock-in
and R6/2). Indeed in young mice expanded htt produced resistance to
Ca2+ [18]. Similarly, Oliveira et al. [113], using the slow Ca2+ infusion
technique [8] with isolated mouse forebrain mitochondria in the
presence of adenine nucleotides, albumin and oligomycin to optimize
mitochondrial stability observed either no reduction in Ca2+
accumulation capacity (Hdh150 knock-in mice) or a statistically
signiﬁcant increase (R6/2 and YAC128 mice).
The variable and somewhat confusing data on mitochondrial Ca2+
handling obtained with the isolated organelles has favoured investi-
gations with intact cultured neurons. The advantages are that pure
neuronal mitochondria are present in their physiological milieu, that
artifacts associated with themitochondrial preparation are absent and
that the mitochondria can be exposed to patho-physiologically
relevant stresses. The limitation of course is that studies are restricted
to neonatal preparations and that the age-related component of the
disease cannot be modeled. This review has emphasized the
importance of considering mitochondrial bioenergetics and Ca2+
transport in parallel. A major experimental deﬁciency until recently
has been the lack of sensitive techniques to monitor the respiration of
cultured neurons. This was resolved with the development of the cell
respirometer [114] which allows the respiration of coverslip-attached
cells to be monitored in parallel with single cell ﬂuorescent functional
analysis. In our experience the small amount of material means that it
is difﬁcult to prepare ‘well coupled’ isolated mitochondria from
speciﬁc brain regions of single transgenic mice. Indeed, in the HD
literature it is difﬁcult to ﬁnd details of the basic respiratory control
parameters for the various preparations used for Ca2+ transport
studies, raising the suspicion that, as in our hands, the preparations
may be functionally compromised. By avoiding isolation artifacts, the
cell respirometer allows the respiratory parameters to be determined
in situ.
A decrease in ‘spare respiratory capacity’, the ability of in situ
mitochondria to increase their respiration in response to an increased
ATP demand has been proposed to be an important factor deﬁning the
long-term survivability of neurons in the face of a variable energy
demand [57]. In view of the evidence that Complex II may be deﬁcient
in HD it was somewhat surprising that analysis of the respiration of
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(Hdh150/+) litter mates revealed no signiﬁcant difference in maximal
respiratory capacity in the presence of the protonophore FCCP [113]
and that in the basal state the mitochondria were only respiring at
about 20% of their respiratory capacity, half of which drove the
endogenous mitochondrial proton leak. In the basal state only 10% of
the total ATP generating capacity was used by the wild-type
mitochondria and 14% by the heterozygous knock-in. Thus, it is likely
that in situ neuronal mitochondria present more robust respiratory
properties than commonly isolated brain mitochondria. Despite this,
parallel determination at single cell resolution of [Ca2+]c using the
low-afﬁnity Fura-5F and mitochondrial membrane potential with
TMRM+ showed a statistically signiﬁcant increase in the proportion of
Hdh150/+ neurons undergoing DCD during a 10 min exposure to
NMDA relative to control Hdh+/+ neurons [113].
4. Conclusions
The four basic principles of isolated brain mitochondrial Ca2+
transport, net accumulation when [Ca2+]c rises above the ‘set-point’,
storage in the alkaline matrix as a calcium–phosphate complex,
controlled release when a low [Ca2+]c is restored by the plasma
membrane and ﬁnally catastrophic dysfunction associated with Ca2+
overload and oxidative stress, can each be observed in intact neurons.
However while all mitochondria can be induced to undergo a
permeability transition, pathological conditions where such Ca2+
overload might occur are more restricted, with the strongest evidence
being the association with chronic NMDA receptor activation in
glutamate excitotoxicity. Since mitochondrial Ca2+ transport is driven
by the proton circuit and thus competes with ATP synthesis it is
essential to consider the interactions between these two processes,
particularly since NMDA receptor activation induces a heavy cellular
ATP demand. Finally, the severe limitation in interpreting studies with
isolated brain mitochondria in models of neurodegenerative diseases
such as Huntington's means that studies with intact neurons are more
likely to provide some insight into the contribution of mitochondrial
Ca2+ transport to the pathology of the disease.
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